Current Issue

Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD

A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.

Portal-based population health screening appears effective for depression

Patients who received emails inviting them to complete an online screener via a patient portal were more likely to be screened for depression and had a higher rate of positive screens than those who received usual care, a single-center study found.

MKSAP Quiz: Elevated INR found on routine monitoring

A 75-year-old man is evaluated for an elevated INR found on routine monitoring. He is otherwise well and has no evidence of bleeding. Following lab studies and stopping warfarin, what is the most appropriate additional management?

Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find

A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.

ACP's Washington, D.C., office seeks applicants for spring 2023 Health Policy Internship Program

The annual internship program provides an opportunity for one medical student and one resident to help with researching and analyzing current issues in health and medical education policy, promoting ongoing advocacy initiatives, and developing advocacy materials.

Put words in our mouth

ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.